Literature DB >> 15084526

Cardiac effects of anabolic steroids.

J R Payne, P J Kotwinski, H E Montgomery.   

Abstract

Anabolic steroid abuse in athletes has been associated with a wide range of adverse conditions, including hypogonadism, testicular atrophy, impaired spermatogenesis, gynaecomastia, and psychiatric disturbance. But what effect does steroid abuse have on the cardiovascular system?

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15084526      PMCID： PMC1768197          DOI： 10.1136/hrt.2003.025783

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  18 in total

Review 1.  Sports-specific adaptations and differentiation of the athlete's heart.

Authors:  A Urhausen; W Kindermann
Journal:  Sports Med       Date:  1999-10       Impact factor: 11.136

2.  Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.

Authors:  L A Curry; D F Wagman
Journal:  Percept Mot Skills       Date:  1999-02

3.  Functional relevance of aldosterone for the determination of left ventricular mass.

Authors:  Christian Delles; Bernhard M W Schmidt; Hans J Müller; Sebastian Oehmer; Arnfried U Klingbeil; Roland E Schmieder
Journal:  Am J Cardiol       Date:  2003-02-01       Impact factor: 2.778

4.  Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).

Authors: 
Journal:  Am J Cardiol       Date:  1996-10-15       Impact factor: 2.778

5.  Left ventricular structural characteristics in Cushing's syndrome.

Authors:  F Fallo; S Budano; N Sonino; M L Muiesan; E Agabiti-Rosei; M Boscaro
Journal:  J Hum Hypertens       Date:  1994-07       Impact factor: 3.012

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training.

Authors:  H E Montgomery; P Clarkson; C M Dollery; K Prasad; M A Losi; H Hemingway; D Statters; M Jubb; M Girvain; A Varnava; M World; J Deanfield; P Talmud; J R McEwan; W J McKenna; S Humphries
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

8.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 9.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

10.  Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function.

Authors:  B De Piccoli; F Giada; A Benettin; F Sartori; E Piccolo
Journal:  Int J Sports Med       Date:  1991-08       Impact factor: 3.118
View more
  22 in total

1.  Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis.

Authors:  Antonello D'Andrea; Pio Caso; Gemma Salerno; Raffaella Scarafile; Giuseppe De Corato; Claudia Mita; Giovanni Di Salvo; Sergio Severino; Sergio Cuomo; Biagio Liccardo; Nicolino Esposito; Raffaele Calabrò
Journal:  Br J Sports Med       Date:  2006-12-18       Impact factor: 13.800

Review 2.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

3.  Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid.

Authors:  Pedro P Pereira-Junior; Elen A Chaves; Ricardo H Costa-E-Sousa; Masako O Masuda; Antonio C Campos de Carvalho; José H M Nascimento
Journal:  Eur J Appl Physiol       Date:  2005-12-13       Impact factor: 3.078

4.  Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view.

Authors:  András Varró; István Baczkó
Journal:  Pflugers Arch       Date:  2010-02-26       Impact factor: 3.657

5.  Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysis.

Authors:  Antonello D'Andrea; Juri Radmilovic; Stefano Caselli; Andreina Carbone; Raffaella Scarafile; Simona Sperlongano; Giampaolo Tocci; Tiziana Formisano; Francesca Martone; Biagio Liccardo; Michele D'Alto; Eduardo Bossone; Maurizio Galderisi; Paolo Golino
Journal:  Int J Cardiovasc Imaging       Date:  2018-10       Impact factor: 2.357

6.  [Cardiovascular alterations associated with doping].

Authors:  D Thieme; A Büttner
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 7.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

8.  Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise.

Authors:  Gustavo Barbosa Dos Santos; Marcelo José Machado Rodrigues; Estela Maria Gonçalves; Maria Cristina Cintra Gomes Marcondes; Miguel Arcanjo Areas
Journal:  Eurasian J Med       Date:  2013-10

9.  Effect of exercise training and anabolic androgenic steroids on hemodynamics, glycogen content, angiogenesis and apoptosis of cardiac muscle in adult male rats.

Authors:  Asmaa F Hassan; Manal M Kamal
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

10.  Global gene expression of fission yeast in response to cisplatin.

Authors:  L Gatti; D Chen; G L Beretta; G Rustici; N Carenini; E Corna; D Colangelo; F Zunino; J Bähler; P Perego
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.